Antimicrobial 14-helical β-peptides: Potent bilayer disrupting agents

Biochemistry

Volumn 43, Issue 29, 2004, Pages 9527-9535

  Epand, Raquel F ^a   Raguse, Tami L ^b   Gellman, Samuel H ^b   Epand, Richard M ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CONFORMATIONS; DIFFUSION; PHOSPHOLIPIDS; POLYPEPTIDES;

MEMBRANE BINDING; MICROBIAL MEMBRANES;

BIOCHEMISTRY;

BETA PEPTIDE; POLYALANYLMAGAININ 2 AMIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ALPHA HELIX; ANTIMICROBIAL ACTIVITY; ARTICLE; BILAYER MEMBRANE; CONFORMATIONAL TRANSITION; DIFFUSION; DRUG CONFORMATION; DRUG STRUCTURE; HEMOLYSIS; MEMBRANE BINDING; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CIRCULAR DICHROISM; LIPID BILAYERS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 3242701305     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049414l     Document Type: Article

References (34)

1. Tossi, A., Sandri, L., and Giangaspero, A. (2000) Amphipathic, α-helical antimicrobial peptides, Biopolymers 55, 4-30.
2. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms, Nature 415, 389-395.
3. Patch, J. A., and Barron, A. E. (2002) Mimicry of bioactive peptides via nonnatural, sequence-specific peptidomimetic oligomers, Curr. Opin. Chem. Biol. 6, 872-877.
4. Tew, G. N., Liu, D., Chen, B., Doerksen, R. J., Kaplan, J., Carroll, P. J., Klein, M. L., and DeGrado, W. F. (2002) De novo design of biomimetic antimicrobial polymers, Proc. Natl. Acad. Sci. U.S.A 99, 5110-5114.
5. Seebach, D., Abele, S., Schreiber, J. V., Martinoni, B., Nussbaum, A. K., Schild, H., Schulz, H., Hennecke, H., Woessner, R., and Bitsch, F. (1998) Biological and pharmacokinetic studies with α-peptides, Chimia 52, 734-739.
6. Cheng, R. P., Gellman, S. H., and DeGrado, W. F. (2001) β-Peptides: from structure to function, Chem. Rev. 101, 3219-3232.
7. Hamuro, Y., Schneider, J. P., and DeGrado, W. F. (1999) De novo design of antibacterial β-peptides, J. Am. Chem. Soc. 121, 12200-12201.
8. Porter, E. A., Wang, X., Lee, H. S., Weisblum, B., and Gellman, S. H. (2000) Nonhaemolytic β-amino acid oligomers, Nature 404, 565.
9. Liu, D., and DeGrado, W. F. (2001) De Novo design, synthesis, and characterization of antimicrobial peptides, J. Am. Chem. Soc. 123, 7553-7559.
10. LePlae, P. R., Fisk, J. D., Porter, E. A., Weisblum, B., and Gellman, S. H. (2002) Tolerance of acyclic residues in the β-peptide 12-helix: access to diverse side-chain arrays for biological applications, J. Am. Chem. Soc. 124, 6820-6821.
11. Porter, E. A., Weisblum, B., and Gellman, S. H. (2002) Mimicry of host-defense peptides by unnatural oligomers: Antimicrobial β-peptides, J. Am. Chem. Soc. 124, 7324-7330.
12. Raguse, T. L., Porter, E. A., Weisblum, B., and Gellman, S. H. (2002) Structure-activity studies of 14-helical antimicrobial β-peptides: Probing the relationship between conformational stability and antimicrobial potency, J. Am. Chem. Soc. 124, 12774-12785.
13. Epand, R. F., Umezawa, N., Porter, E. A., Gellman, S. H., and Epand, R. M. (2003) Interactions of the antimicrobial β-peptide β-17 with phospholipid vesicles differ from membrane interactions of magainins, Eur. J. Biochem. 270, 1240-1248.
14. Berkessel, A., Glaubitz, K., and Lex, J. (2002) J. Org. Chem. 17, 2948.
15. Schinnerl, M., Murray, J. K., Langenhan, J. M., and Gellman, S. H. (2003) Asymmetric synthesis of a new helix-forming β-amino acid: trans-4-aminopiperidine-3-carboxylic acid, Eur. J. Org. Chem. 721-726.
16. Appella, D. H., Barchi, J. J., Durell, S. R., and Gellman, S. H. (1999) Formation of short, stable helices in aqueous solution by β-amino acid hexamers, J. Am. Chem. Soc. 121, 2309-2310.
17. Raguse, T. L., Lai, J. R., and Gellman, S. H. (2003) Environment- independent 14-helix formation in short β-peptides: striking a balance between shape control and functional diversity, J Am. Chem. Soc. 125, 5592-5593.
18. Ames, B. N. (1966) Assay of inorganic phosphate, total phosphate, and phosphatases., Methods Enzymol. 8, 115-118.
19. Peitzsch, R. M., and McLaughlin, S. (1993) Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins, Biochemistry 32, 10436-10443.
20. Ben Tal, N., Honig, B., Miller, C., and McLaughlin, S. (1997) Electrostatic binding of proteins to membranes. Theoretical predictions and experimental results with charybdotoxin and phospholipid vesicles, Biophys. J. 73, 1717-1727.
21. 2+-induced fusion and destabilization of liposomes, Biochemistry 24, 3099-3106.
22. Struck, D. K., Hoekstra, D., and Pagano, R. E. (1981) Use of resonance energy transfer to monitor membrane fusion, Biochemistry 20, 4093-4099.
23. Muller, P., Schiller, S., Wieprecht, T., Dathe, M., and Herrmann, A. (2000) Continuous measurement of rapid transbilayer movement of a pyrene-labeled phospholipid analogue, Chem. Phys. Lipids 106, 89-99.
24. Epand, R. M. (2003) Fusion peptides and the mechanism of viral fusion, Biochim. Biophys. Acta 1614, 116-121.
25. Davies, S. M., Epand, R. F., Bradshaw, J. P., and Epand, R. M. (1998) Modulation of lipid polymorphism by the feline leukemia virus fusion peptide: implications for the fusion mechanism, Biochemistry 37, 5720-5729.
26. Chen, H. C., Brown, J. H., Morell, J. L., and Huang, C. M. (1988) Synthetic magainin analogues with improved antimicrobial activity, FEBS Lett. 236, 462-466.
27. Lee, H. S., Syud, F. A., Wang, X. F., and Gellman, S. H. (2001) Diversity in short β-peptide 12-helices: High-resolution structural analysis in aqueous solution of a hexamer containing sulfonylated pyrrolidine residues, J. Am. Chem. Soc. 123, 7721-7722.
28. Hara, T., Kodama, H., Kondo, M., Wakamatsu, K., Takeda, A., Tachi, T., and Matsuzaki, K. (2001) Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue, Biopolymers 58, 437-446.
29. Matsuzaki, K., Sugishita, K., Ishibe, N., Ueha, M., Nakata, S., Miyajima, K., and Epand, R. M. (1998) Relationship of membrane curvature to the formation of pores by magainin 2, Biochemistry 37, 11856-11863.
30. Epand, R. M., Epand, R. F., Martin, I., and Ruysschaert, J. M. (2001) Membrane interactions of mutated forms of the influenza fusion peptide, Biochemistry 40, 8800-8807.
31. Epand, R. M. (1998) Lipid polymorphism and protein-lipid interactions, Biochim. Biophys. Acta 1376, 353-368.
32. Oh, J. T., Cajal, Y., Skowronska, E. M., Belkin, S., Chen, J., Van Dyk, T. K., Sasser, M., and Jain, M. K. (2000) Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli, Biochim. Biophys. Acta 1463, 43-54.
33. Markin, V. S., Kozlov, M. M., and Borovjagin, V. L. (1984) On the theory of membrane fusion. The stalk mechanism, Gen. Physiol. Biophys. 3, 361-377.
34. Ding, L., Yang, L., Weiss, T. M., Waring, A. J., Lehrer, R. I., and Huang, H. W. (2003) Interaction of antimicrobial peptides with lipopolysaccharides, Biochemistry 42, 12251-12259.